The former official asked not to be named to avoid a public debate with the industry
The tech founder has argued for the widespread use of GLP-1 inhibitors to fight obesity a hot-topic issue for the upcoming Donald Trump presidency given Medicare does not currently cover the drug
[DOI] [PMC free article] [PubMed] [Google Scholar] Shi JF, Li YK, Ren K, Xie YJ, Yin WD, Mo ZC, 2018
ScienceDirect,
Example Weekly Schedule The documented framing is once daily
Supplementary material Rights and permissions Open Access: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made